# EDGAR Filing Document

**Accession Number:** 0001938046
**File Stem:** 0001493152-23-005804
**Filing Date:** 2023-2
**Character Count:** 2169
**Document Hash:** f799623dec77d9bbfe4384f50eb0aa27
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-005804.hdr.sgml**: 20230418

**ACCESSION NUMBER**: 0001493152-23-005804

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230222

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MANGOCEUTICALS, INC.
- **CENTRAL INDEX KEY:** 0001938046
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **IRS NUMBER:** 873841292
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 15110 DALLAS PKWY, SUITE 600
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75248
- **BUSINESS PHONE:** (833) 626-4679

**MAIL ADDRESS:**
- **STREET 1:** 15110 DALLAS PKWY, SUITE 600
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75248

February 22, 2023

**<u>VIA EDGAR</u>**

Division of Corporation Finance

U.S. Securities & Exchange Commission

100 F Street, NE

Washington, DC 20549

Attn: Office of Industrial Applications and Services

---

| | |
|:---|:---|
| Re: | **Withdrawal of Acceleration Request of Mangoceuticals, Inc.** |
|  | **Registration Statement on Form S-1** |
|  | **File No. 333-269240** |

---

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on February 10, 2023, in which we, as representative of the several underwriters of Mangoceuticals, Inc.'s proposed public offering, joined Mangoceuticals, Inc.'s request for acceleration of the effective date of the above-referenced Registration Statement for 4:00 p.m. Eastern time on Tuesday, February 14, 2023, or as soon thereafter as practicable. Mangoceuticals, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

*[Signature page follows]*

 

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Boustead Securities, LLC | Boustead Securities, LLC |
| By: | */s/ Keith Moore* |
| Name: | Keith Moore |
| Title: | CEO |
| As representative of the underwriters | As representative of the underwriters |

---